gurufocus.com · 2 jul

Merck & Co Inc (MRK) Shares Surge 3.3% -- What GF Score of 78 Tells Investors

On July 02, 2026, Merck and Co Inc (MRK) shares rose 3.3% today, currently priced at $129.56. The stock has experienced significant price appreciation, trading wi

investors.com · 2 jul

Merck Stock, JPMorgan And Two Others Hit New Highs

Merck stock is in a buy zone after hitting a new high. Fellow Dow stock JPMorgan Chase and Amphenol are both trading around entry points.

fool.com · 1 jul

Schwab vs. Vanguard: Which Dividend ETF Is Best for Your Portfolio?

Portfolio concentration and sector weightings set these two popular income funds apart for investors seeking steady cash flow.

businesswire.com · 1 jul

Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4

RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4.

proactiveinvestors.com · 30 jun

Merck, AbbVie probed by US lawmakers over China clinical trials: report

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck and AbbVie, were involved in clinical trials conducted in China that may have supported the country's military capabilities, according to a Reuters report. The inquiry, led by Republican Representative John Moolenaar of Michigan, chair of the House Select Committee on China, focuses on whether the drugmakers conducted adequate due diligence and maintained sufficient data protection standards at trial sites in China.

schaeffersresearch.com · 30 jun

Stock Futures Quiet to End the Month, Quarter

Stock futures are pointed lower to end the month and quarter as AI capex concerns linger

proactiveinvestors.com · 30 jun

Merck, AbbVie probed by US lawmakers over China clinical trials: report

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck...

fool.com · 30 jun

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?